Global Ngs Based Rna Sequencing Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Ngs Based Rna Sequencing Market Analysis

  • Healthcare
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

NGS-basierte RNA-Sequenzierung wird häufig für anspruchsvolle und umfassende genomische Erkenntnisse sowohl in Standard- als auch in nicht-traditionellen Anwendungen eingesetzt. Die wachsende Nachfrage nach besserer sequenzierungsbasierter Diagnostik hat die Entwicklung neuartiger Sequenzierungstechnologien vorangetrieben. Infolgedessen ist die Nachfrage nach Technologien wie Hochdurchsatzsequenzern und tragbaren Geräten sprunghaft gestiegen. Der Markt für NGS-basierte RNA-Sequenzierung wächst aus verschiedenen Gründen, darunter technologische Entwicklungen bei RNA-Sequenzierungsprodukten, die Vorteile von RNA-Sequenzierung gegenüber der Microarray-Technologie, die rasante Ausweitung der Forschungsaktivitäten, eine Zunahme von RNA-Sequenzierungsauszeichnungen und ein hoher Bedarf an Präzisionsmedizin.

Filled Map Analysis

Frequently Asked Questions

The market is segmented based on Global NGS-Based RNA-Sequencing Market Segmentation, By Product and Services (RNA Sequencing Platforms and Consumables, Sample Preparation Products, RNA Sequencing Services, Data Analysis, Storage and Management),Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) – Industry Trends and Forecast to 2032 .
The Global Ngs Based Rna Sequencing Market size was valued at USD 4.21 USD Billion in 2024.
The Global Ngs Based Rna Sequencing Market is projected to grow at a CAGR of 19.9% during the forecast period of 2025 to 2032.
The major players operating in the market include Illumina Inc. ,Thermo Fischer Scientific Inc. ,Oxford Nanopore Technologies plc AGilent TechnologiesInc. ,BGI ,PerkinElmer Inc. ,QIAGEN ,Eurofins Scientific ,F. Hoffmann-La Roche Ltd ,Takara Bio Inc. ,GENEWIZInc. ,Hamilton Company ,Macrogen Inc. ,Zymo Research Corporation ,Tecan Trading AG .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.